Astellas Pharma Inc Unsponsored ADR (ALPMY)

Astellas Pharma Inc Unsponsored ADR (ALPMY) – Corporate News

Jan 26, 2024 12:01 PM Pfizer (PFE) Announces EMA Validates Type II Variation Application for PADCEV with KEYTRUDA for First-Line Treatment of Advanced Bladder Cancer
Apr 30, 2023 09:24 PM Astellas Pharma to acquire Iveric Bio (ISEE) for $5.9 billion
Dec 17, 2021 06:40 AM
Sep 20, 2021 05:46 AM
Jul 9, 2021 02:12 PM
Jun 25, 2021 08:58 AM
May 19, 2021 05:21 PM
Apr 19, 2021 08:04 AM
Mar 26, 2021 06:32 AM
Feb 18, 2021 08:03 AM
Feb 12, 2021 02:16 PM
Oct 14, 2020 07:08 AM
Oct 12, 2020 06:46 AM
May 29, 2020 08:20 AM
Mar 24, 2020 09:06 AM
Feb 10, 2020 05:02 PM
Dec 19, 2019 06:27 AM
Dec 16, 2019 06:05 PM
Dec 2, 2019 08:04 AM
Jul 16, 2019 08:04 AM
Feb 11, 2019 05:01 PM
Oct 1, 2018 08:12 AM
Jul 13, 2018 02:33 PM
Jul 9, 2018 08:03 AM
Mar 19, 2018 04:16 PM
Jun 9, 2017 08:07 AM
Dec 14, 2016 04:22 PM
Oct 21, 2016 11:58 AM
Oct 10, 2016 06:24 AM
Jul 27, 2016 07:33 AM
Jun 6, 2016 08:05 AM
Jun 2, 2016 07:06 AM
Apr 7, 2016 07:02 AM
Mar 24, 2016 07:12 AM
Jan 26, 2016 04:20 PM